Karen Bardossi
TRT, blood clot risk evaluated in large analysis
Middle-aged and older men undergoing testosterone replacement therapy aren’t at increased risk of venous thromboembolism (VTE), the results of a large comparative case-control analysis published online in Mayo Clinic Proceedings (July 15, 2015) suggest.
Study: No significant link between diabetes Tx, bladder Ca
Study: No significant link between diabetes Tx, bladder Ca
A new study reports no statistically significant increase in the risk of bladder cancer among patients treated with the diabetes drug pioglitazone (Actos), despite previous studies suggesting an association.
Low-risk PCa: Higher radiation dose shows no benefit
Higher radiation doses don’t confer a survival benefit in men with low-risk prostate cancer, although they do increase survival rates for men with medium- and high-risk cancers, the authors of a new study report.
Mid-urethral slings demonstrate efficacy, few adverse effects
A recently published review expands understanding of the effectiveness and side effects of mid-urethral sling procedures for stress urinary incontinence, providing more information for women considering minimally invasive surgical treatment.
Active surveillance on the rise but still underused
Despite the strategy’s benefits, many low-risk patients still undergo surgical or radiation treatment, researchers report.
Diet, urine pH may affect urinary tract bacterial growth
The recently published findings may open new avenues for treating urinary tract infections.
Weight-loss surgery may reduce incontinence
The authors of a recently published study have found that bariatric surgery may provide a significant benefit beyond dramatic weight loss.
Overactive bladder: Two drugs found better than one
Overactive bladder: Two drugs found better than one
A two-drug treatment regimen works better than monotherapy for incontinent overactive bladder patients, researchers reported at the AUA annual meeting in New Orleans.
Green tea may suppress prostate cancer in high-risk men
Chemicals in green tea may help inhibit development of prostate cancer in men at high risk, according to results of a randomized, controlled trial.
Urine test accurately predicts high-grade prostate Ca
An experimental assay could reduce the need for prostate needle biopsies, researchers say.